Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $422 Billion
  • Q3 2024

Decheng Capital LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $422 Billion distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $207B, Nuvation Bio Inc. with a value of $59.4B, Phathom Pharmaceuticals, Inc. with a value of $22.6B, Arcus Biosciences, Inc. with a value of $13.3B, and Krystal Biotech, Inc. with a value of $13.1B.

Examining the 13F form we can see an increase of $95.9B in the current position value, from $326B to 422B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $422 Billion
Healthcare: $193 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$21.4B
$12.4 Billion 2.93% of portfolio
94,767
Q3 2024 Reduced 12.87%

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $422 Billion
  • Prior Value $326 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email